Yuan Jiandong & family

Net Worth

$1.449B

0% (24h)

Yuan Jiandong is the chairman of BrightGene Bio-Medical Technology, a Shanghai-listed pharmaceutical supplier, and is recognized for his significant contributions to the healthcare industry. After graduating from Peking University and the State University of New York, he worked at Enzo Biochem before returning to China to found BrightGene. As of early 2026, Yuan Jiandong and his family ranked as #3185 on the Forbes Billionaires list, demonstrating considerable success in the pharmaceutical sector.

The Full Dossier

Early Life and Education

Yuan Jiandong holds an undergraduate degree in chemistry from Peking University and a Ph.D. in chemistry from the State University of New York. His academic background in chemistry laid the foundation for his future endeavors in the pharmaceutical industry.

Rise to Success

Yuan's career began with a role at Enzo Biochem from 1998 to 2001. He then returned to China to establish BrightGene Bio-Medical Technology. BrightGene has since become a key player in the pharmaceutical market.

Key Business Strategies

Under Yuan Jiandong's leadership, BrightGene has focused on the research, development, and manufacturing of brand-name and generic drugs. His strategic vision has driven the company's growth and success. BrightGene is listed on the Shanghai Stock Exchange.

Philanthropy

Yuan Jiandong is involved in philanthropy through the Yuan Family Foundation. The foundation's finances show a focus on charitable activities.

Career Timeline

2001

Founded BrightGene

Returned to China to start BrightGene Bio-Medical Technology.

1998

Enzo Biochem

Worked at Enzo Biochem.

Philanthropic Impact

Philanthropy$0.0647B (2024 revenue)

Yuan Family Foundation

The Yuan Family Foundation is a 501(c)(3) organization.